Rating History for Tourmaline Bio (TRML) by BMO Capital
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 9/15/2025 | Kostas Biliouris | Downgrade | Market Perform (Outperform) |
48.00 (35.00) |
47.60 (47.98) |
0.8% | Details |
 |
|||||||
|
|||||||
|
|||||||
